242 related articles for article (PubMed ID: 28633676)
21. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996-2006).
Saam DE; Liptak JM; Stalker MJ; Chun R
J Am Vet Med Assoc; 2011 Jan; 238(2):195-206. PubMed ID: 21235373
[TBL] [Abstract][Full Text] [Related]
22. STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial.
Vail DM; Kurzman ID; Glawe PC; O'Brien MG; Chun R; Garrett LD; Obradovich JE; Fred RM; Khanna C; Colbern GT; Working PK
Cancer Chemother Pharmacol; 2002 Aug; 50(2):131-6. PubMed ID: 12172978
[TBL] [Abstract][Full Text] [Related]
23. Canine osteosarcoma: amputation and chemoimmunotherapy.
MacEwen EG; Kurzman ID
Vet Clin North Am Small Anim Pract; 1996 Jan; 26(1):123-33. PubMed ID: 8825571
[TBL] [Abstract][Full Text] [Related]
24. Canine osteosarcoma. Treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin.
Mauldin GN; Matus RE; Withrow SJ; Patnaik AK
J Vet Intern Med; 1988; 2(4):177-80. PubMed ID: 3230557
[TBL] [Abstract][Full Text] [Related]
25. The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro.
Marley K; Helfand SC; Edris WA; Mata JE; Gitelman AI; Medlock J; Séguin B
BMC Vet Res; 2013 Jan; 9():15. PubMed ID: 23331343
[TBL] [Abstract][Full Text] [Related]
26. Adverse events and outcomes in dogs with appendicular osteosarcoma treated with limb amputation and a single subcutaneous infusion of carboplatin.
Santamaria AC; Simcock JO; Kuntz CA
J Am Vet Med Assoc; 2019 Aug; 255(3):345-351. PubMed ID: 31298641
[TBL] [Abstract][Full Text] [Related]
27. Results of surgery and doxorubicin chemotherapy in dogs with osteosarcoma.
Berg J; Weinstein MJ; Springfield DS; Rand WM
J Am Vet Med Assoc; 1995 May; 206(10):1555-60. PubMed ID: 7775232
[TBL] [Abstract][Full Text] [Related]
28. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
29. Investigating CXCR4 expression in canine appendicular osteosarcoma.
Fan TM; Barger AM; Fredrickson RL; Fitzsimmons D; Garrett LD
J Vet Intern Med; 2008; 22(3):602-8. PubMed ID: 18466248
[TBL] [Abstract][Full Text] [Related]
30. Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma.
Chun R; Garrett LD; Henry C; Wall M; Smith A; Azene NM
J Am Anim Hosp Assoc; 2005; 41(6):382-7. PubMed ID: 16267062
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979-1990).
Thompson JP; Fugent MJ
J Am Vet Med Assoc; 1992 Feb; 200(4):531-3. PubMed ID: 1559895
[TBL] [Abstract][Full Text] [Related]
32. Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.
London CA; Gardner HL; Mathie T; Stingle N; Portela R; Pennell ML; Clifford CA; Rosenberg MP; Vail DM; Williams LE; Cronin KL; Wilson-Robles H; Borgatti A; Henry CJ; Bailey DB; Locke J; Northrup NC; Crawford-Jakubiak M; Gill VL; Klein MK; Ruslander DM; Thamm DH; Phillips B; Post G
PLoS One; 2015; 10(4):e0124889. PubMed ID: 25923466
[TBL] [Abstract][Full Text] [Related]
33. The animal-dependent risk factors in canine osteosarcomas.
Sapierzyński R; Czopowicz M
Pol J Vet Sci; 2017 Mar; 20(2):293-298. PubMed ID: 28865206
[TBL] [Abstract][Full Text] [Related]
34. Toxicity and efficacy of a novel doxorubicin and carboplatin chemotherapy protocol for the treatment of canine appendicular osteosarcoma following limb amputation.
Lane A; Black M; Wyatt K
Aust Vet J; 2012 Mar; 90(3):69-74. PubMed ID: 22339117
[TBL] [Abstract][Full Text] [Related]
35. Flow Cytometric Detection of Circulating Osteosarcoma Cells in Dogs.
Wright T; Brisson BA; Wood GA; Oblak M; Mutsaers AJ; Sabine V; Skowronski K; Belanger C; Tiessen A; Bienzle D
Cytometry A; 2019 Sep; 95(9):997-1007. PubMed ID: 31282052
[TBL] [Abstract][Full Text] [Related]
36. Which dogs with appendicular osteosarcoma benefit most from chemotherapy after surgery? Results from an individual patient data meta-analysis.
Schmidt AF; Groenwold RH; Amsellem P; Bacon N; Klungel OH; Hoes AW; de Boer A; Kow K; Maritato K; Kirpensteijn J; Nielen M
Prev Vet Med; 2016 Mar; 125():116-25. PubMed ID: 26796424
[TBL] [Abstract][Full Text] [Related]
37. Use of cisplatin for treatment of appendicular osteosarcoma in dogs.
Shapiro W; Fossum TW; Kitchell BE; Couto CG; Theilen GH
J Am Vet Med Assoc; 1988 Feb; 192(4):507-11. PubMed ID: 3163684
[TBL] [Abstract][Full Text] [Related]
38. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993).
Bergman PJ; MacEwen EG; Kurzman ID; Henry CJ; Hammer AS; Knapp DW; Hale A; Kruth SA; Klein MK; Klausner J; Norris AM; McCaw D; Straw RC; Withrow SJ
J Vet Intern Med; 1996; 10(2):76-81. PubMed ID: 8683484
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of copper chaperones sensitizes human and canine osteosarcoma cells to carboplatin chemotherapy.
Inkol JM; Poon AC; Mutsaers AJ
Vet Comp Oncol; 2020 Dec; 18(4):559-569. PubMed ID: 32060984
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcome of 42 dogs with scapular tumors treated by scapulectomy: a Veterinary Society of Surgical Oncology (VSSO) retrospective study (1995-2010).
Montinaro V; Boston SE; Buracco P; Culp WT; Romanelli G; Straw R; Ryan S
Vet Surg; 2013 Nov; 42(8):943-50. PubMed ID: 24433298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]